Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Demineralized Bone Matrix Market by Type (Allograft, Autograft) and by Applications (Joint, Dental, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A02367

Pages: NA

Charts: NA

Tables: NA

Demineralized bone matrix (DBM) is an allograft bone from which the inorganic mineral is removed and leaves behind collagen (structural protein) matrix. The removal of the bone mineral further results in exposing more biologically active bone morphogenetic proteins (growth factors). Further, demineralized bone matrix is used to extend and bolster the bone graft. This is due to the ability of growth factors to control the differentiation of progenitor cells, which are responsible for bone and cartilage formation.

Hence, demineralized bone matrix (DBM) is more biologically active as compared to mineralized bone grafts and aids in bone generation. The demineralized bone matrix market is expected to grow rapidly owing to the advancements and innovations in the field of grafting and the sudden surge in cosmetic surgery. In addition, the increase in soft tissue allograft and increase in demand of surgical procedures for younger generation and athletics will certainly result in the growth of this market.

Further, the high cost of bone grafting and minimal awareness among the population especially in the developing countries such as China, India, Brazil, and others impede the growth of the demineralized bone matrix market.

The global demineralized bone matrix market is segmented based on type, applications, and region. Based on type, the market is bifurcated into allograft and autograft bone grafting. Based on applications, it is classified into joint, dental, and other. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as NovaBone Products, Zimmer Biomet, Exactech, Inc., AlloSource, LifeNet Health, Inc., Smith & Nephew., DePuy Synthes Companies, Medtronic plc, Wright Medical Group and Baxter International, Inc. is also provided in this report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global demineralized bone matrix market.
  • In-depth analysis is conducted by constructing market estimations for the key market segments.
  • This study evaluates the competitive landscape and value chain is taken into account to help understand the competitive environment across the geographies.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • This report provides the quantitative analysis of the current market and estimations which assists in identifying the prevailing market opportunities

 Key Market Segments

  • By Type
    • Allograft
    • Autograft
  • By Applications
    • Joint
    • Dental
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • DePuy Synthes Companies
  • NovaBone Products
  • AlloSource
  • Zimmer Biomet
  • Smith & Nephew
  • LifeNet Health, Inc.
  • Medtronic plc.
  • Baxter International
  • Exactech, Inc.
  • Wright Medical Group

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: DEMINERALIZED BONE MATRIX MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Allograft

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Autograft

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: DEMINERALIZED BONE MATRIX MARKET, BY APPLICATIONS

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Applications

    • 5.2. Joint

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Dental

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: DEMINERALIZED BONE MATRIX MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Applications

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Demineralized Bone Matrix Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Applications

      • 6.2.6. Canada Demineralized Bone Matrix Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Applications

      • 6.2.7. Mexico Demineralized Bone Matrix Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Applications

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Applications

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Demineralized Bone Matrix Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Applications

      • 6.3.6. Germany Demineralized Bone Matrix Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Applications

      • 6.3.7. Italy Demineralized Bone Matrix Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Applications

      • 6.3.8. Spain Demineralized Bone Matrix Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Applications

      • 6.3.9. UK Demineralized Bone Matrix Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Applications

      • 6.3.10. Russia Demineralized Bone Matrix Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Applications

      • 6.3.11. Rest Of Europe Demineralized Bone Matrix Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Applications

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Applications

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Demineralized Bone Matrix Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Applications

      • 6.4.6. Japan Demineralized Bone Matrix Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Applications

      • 6.4.7. India Demineralized Bone Matrix Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Applications

      • 6.4.8. South Korea Demineralized Bone Matrix Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Applications

      • 6.4.9. Australia Demineralized Bone Matrix Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Applications

      • 6.4.10. Thailand Demineralized Bone Matrix Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Applications

      • 6.4.11. Malaysia Demineralized Bone Matrix Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Applications

      • 6.4.12. Indonesia Demineralized Bone Matrix Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Applications

      • 6.4.13. Rest of Asia Pacific Demineralized Bone Matrix Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Applications

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Applications

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Demineralized Bone Matrix Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Applications

      • 6.5.6. South Africa Demineralized Bone Matrix Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Applications

      • 6.5.7. Saudi Arabia Demineralized Bone Matrix Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Applications

      • 6.5.8. UAE Demineralized Bone Matrix Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Applications

      • 6.5.9. Argentina Demineralized Bone Matrix Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Applications

      • 6.5.10. Rest of LAMEA Demineralized Bone Matrix Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Applications

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. NovaBone Products

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Zimmer Biomet

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Exactech, Inc.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. AlloSource

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. LifeNet Health, Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Smith And Nephew

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. DePuy Synthes Companies

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Medtronic Plc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Wright Medical Group

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Baxter International

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR ALLOGRAFT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR AUTOGRAFT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR JOINT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR DENTAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. NORTH AMERICA DEMINERALIZED BONE MATRIX, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 12. U.S. DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 13. U.S. DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 14. CANADA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 15. CANADA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 16. MEXICO DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 18. EUROPE DEMINERALIZED BONE MATRIX, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 21. FRANCE DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 23. GERMANY DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 25. ITALY DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 26. ITALY DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 27. SPAIN DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 29. UK DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 30. UK DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 31. RUSSIA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 33. REST OF EUROPE DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 35. ASIA-PACIFIC DEMINERALIZED BONE MATRIX, BY REGION, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 38. CHINA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 39. CHINA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 40. JAPAN DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 42. INDIA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. INDIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 44. SOUTH KOREA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 46. AUSTRALIA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 48. THAILAND DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 50. MALAYSIA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 52. INDONESIA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 56. LAMEA DEMINERALIZED BONE MATRIX, BY REGION, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 59. BRAZIL DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 61. SOUTH AFRICA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 63. SAUDI ARABIA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 65. UAE DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. UAE DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 67. ARGENTINA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 69. REST OF LAMEA DEMINERALIZED BONE MATRIX, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 71. NOVABONE PRODUCTS: KEY EXECUTIVES
  • TABLE 72. NOVABONE PRODUCTS: COMPANY SNAPSHOT
  • TABLE 73. NOVABONE PRODUCTS: OPERATING SEGMENTS
  • TABLE 74. NOVABONE PRODUCTS: PRODUCT PORTFOLIO
  • TABLE 75. NOVABONE PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. ZIMMER BIOMET: KEY EXECUTIVES
  • TABLE 77. ZIMMER BIOMET: COMPANY SNAPSHOT
  • TABLE 78. ZIMMER BIOMET: OPERATING SEGMENTS
  • TABLE 79. ZIMMER BIOMET: PRODUCT PORTFOLIO
  • TABLE 80. ZIMMER BIOMET: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. EXACTECH, INC.: KEY EXECUTIVES
  • TABLE 82. EXACTECH, INC.: COMPANY SNAPSHOT
  • TABLE 83. EXACTECH, INC.: OPERATING SEGMENTS
  • TABLE 84. EXACTECH, INC.: PRODUCT PORTFOLIO
  • TABLE 85. EXACTECH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. ALLOSOURCE: KEY EXECUTIVES
  • TABLE 87. ALLOSOURCE: COMPANY SNAPSHOT
  • TABLE 88. ALLOSOURCE: OPERATING SEGMENTS
  • TABLE 89. ALLOSOURCE: PRODUCT PORTFOLIO
  • TABLE 90. ALLOSOURCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. LIFENET HEALTH, INC.: KEY EXECUTIVES
  • TABLE 92. LIFENET HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 93. LIFENET HEALTH, INC.: OPERATING SEGMENTS
  • TABLE 94. LIFENET HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 95. LIFENET HEALTH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 97. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 98. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 99. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 100. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. DEPUY SYNTHES COMPANIES: KEY EXECUTIVES
  • TABLE 102. DEPUY SYNTHES COMPANIES: COMPANY SNAPSHOT
  • TABLE 103. DEPUY SYNTHES COMPANIES: OPERATING SEGMENTS
  • TABLE 104. DEPUY SYNTHES COMPANIES: PRODUCT PORTFOLIO
  • TABLE 105. DEPUY SYNTHES COMPANIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. MEDTRONIC PLC.: KEY EXECUTIVES
  • TABLE 107. MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 108. MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 109. MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 110. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. WRIGHT MEDICAL GROUP: KEY EXECUTIVES
  • TABLE 112. WRIGHT MEDICAL GROUP: COMPANY SNAPSHOT
  • TABLE 113. WRIGHT MEDICAL GROUP: OPERATING SEGMENTS
  • TABLE 114. WRIGHT MEDICAL GROUP: PRODUCT PORTFOLIO
  • TABLE 115. WRIGHT MEDICAL GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. BAXTER INTERNATIONAL: KEY EXECUTIVES
  • TABLE 117. BAXTER INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 118. BAXTER INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 119. BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 120. BAXTER INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL DEMINERALIZED BONE MATRIX MARKET SEGMENTATION
  • FIGURE 2. GLOBAL DEMINERALIZED BONE MATRIX MARKET
  • FIGURE 3. SEGMENTATION DEMINERALIZED BONE MATRIX MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN DEMINERALIZED BONE MATRIX MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDEMINERALIZED BONE MATRIX MARKET
  • FIGURE 11. DEMINERALIZED BONE MATRIX MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. DEMINERALIZED BONE MATRIX MARKET FOR ALLOGRAFT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. DEMINERALIZED BONE MATRIX MARKET FOR AUTOGRAFT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. DEMINERALIZED BONE MATRIX MARKET SEGMENTATION, BY BY APPLICATIONS
  • FIGURE 15. DEMINERALIZED BONE MATRIX MARKET FOR JOINT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. DEMINERALIZED BONE MATRIX MARKET FOR DENTAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. DEMINERALIZED BONE MATRIX MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: DEMINERALIZED BONE MATRIX MARKET
  • FIGURE 24. TOP PLAYER POSITIONING, 2024
  • FIGURE 25. NOVABONE PRODUCTS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 26. NOVABONE PRODUCTS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 27. NOVABONE PRODUCTS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 28. ZIMMER BIOMET: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. ZIMMER BIOMET: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. ZIMMER BIOMET: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. EXACTECH, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. EXACTECH, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. EXACTECH, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. ALLOSOURCE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. ALLOSOURCE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. ALLOSOURCE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. LIFENET HEALTH, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. LIFENET HEALTH, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. LIFENET HEALTH, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. SMITH AND NEPHEW: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. DEPUY SYNTHES COMPANIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. DEPUY SYNTHES COMPANIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. DEPUY SYNTHES COMPANIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. MEDTRONIC PLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. WRIGHT MEDICAL GROUP: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. WRIGHT MEDICAL GROUP: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. WRIGHT MEDICAL GROUP: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. BAXTER INTERNATIONAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. BAXTER INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. BAXTER INTERNATIONAL: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Demineralized Bone Matrix Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved